NYSE: RCUS - Arcus Biosciences, Inc.

Rentabilidade por seis meses: -3.89%
Setor: Healthcare

Cronograma de promoção Arcus Biosciences, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa

Arcus Biosciences, Inc., биофармацевтическая компания, работающая на клинической стадии, занимается разработкой и коммерциализацией методов лечения рака в Соединенных Штатах. Ассортимент продукции компании включает AB928, двойной антагонист аденозиновых рецепторов A2aA2b, который проходит фазу 1b2 клинических испытаний; и Зимберелимаб, моноклональное антитело против PD-1, которое проходит фазу Ib клинических испытаний для монотерапии.

Mais detalhes
Он также разрабатывает AB154, моноклональное антитело против TIGIT, которое находится в фазе 2 разработки для лечения метастатического немелкоклеточного рака легкого первой линии в комбинации с зимберелимабом и AB928; и AB680, низкомолекулярный ингибитор CD73, находится в фазе 11b исследования для лечения метастатического рака поджелудочной железы первой линии. Arcus Biosciences, Inc. заключила соглашение о сотрудничестве в области клинической разработки со Strata Oncology, Inc. для оценки Зимберелимаба; и лицензионные соглашения с Taiho Pharmaceutical Co., Ltd, Abmuno Therapeutics LLC и WuXi Biologics (Cayman) Inc. Компания была основана в 2015 году и базируется в Хейворде, Калифорния.

Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

P/S 28.34
P/BV 2.59
EV/EBITDA -4.31
EBITDA -0.0851
Цена ао 18.83
Сайт http://www.arcusbio.com
Число акций ао 0.074 млрд
P/E 60.08
Выручка 0.015
Див.доход ао 0
ISIN US03969F1093
Валюта usd
IPO date 2018-03-15
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Alteração de preço por dia: 0% (14.56)
Alteração de preço por semana: +0.3446% (14.51)
Alteração de preço por mês: -10.78% (16.32)
Alteração de preço em 3 meses: -16.75% (17.49)
Mudança de preço em seis meses: -3.89% (15.15)
Mudança de preço por ano: +3.56% (14.06)
Mudança de preço em 3 anos: -64.22% (40.69)
Mudança de preço em 5 anos: +76.06% (8.27)
Mudança de preço desde o início do ano: -23.77% (19.1)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 11.48 1
P/BV 2.91 6
P/E 15.42 7
EV/EBITDA -4.22 0
Total: 5.38

Eficiência

Nome Significado Nota
ROA, % -28.04 0
ROE, % -66.45 0
Total: 0.3333

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0.2243

Obrigação

Nome Significado Nota
Debt/EBITDA -0.0378 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 680 10
Rentabilidade Ebitda, % 228.07 10
Rentabilidade EPS, % 135.72 10
Total: 10
Mais detalhes

Data da transação Data de divulgação Insider Tipo Preço Volume Quantidade Compartilhe até, % Compartilhe depois, % Documento
27.03.2024 29.03.2024 Jarrett Jennifer
Chief Operating Officer		 Oferta 17.55 202 720 11551 0 -0.02 link
18.03.2024 20.03.2024 Jarrett Jennifer
Chief Operating Officer		 Oferta 17.92 241 006 13449 0 -0.02 link
22.09.2023 26.09.2023 Jarrett Jennifer
Chief Operating Officer		 Oferta 19.99 427 166 21369 0 -0.03 link

Instituições Volume Compartilhar, %
Blackrock Inc. 10035170 11.04
FMR, LLC 4728782 5.2
Vanguard Group Inc 4680716 5.15
State Street Corporation 4239577 4.67
Octagon Capital Advisors LP 1868000 2.06
Ameriprise Financial, Inc. 1634805 1.8
Invus Financial Advisors, LLC 1612077 1.77
Boxer Capital, LLC 1602200 1.76
Dimensional Fund Advisors LP 1594609 1.75
AllianceBernstein L.P. 1185944 1.31

ETF Compartilhar, % Rentabilidade para o ano, % Dividendos, %
Avantis U.S Small Cap Equity ETF 0.08667 27.774101036841 1.68271
Avantis U.S. Equity ETF 0.00372 32.224830464267 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 0.76808 63.040315712071 0.33
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.05678 24.74842126706 1.59225
Range Cancer Therapeutics ETF 1.23035 47.24446537918 0.11955
Dimensional U.S. Core Equity 2 ETF 0.00798 30.755198832543 1.47098
Dimensional US Core Equity Market ETF 0.00355 30.983243755928 1.40618
Dimensional U.S. Equity ETF 0.00155 31.530984204131 1.3557
Dimensional US Marketwide Value ETF 0.0007 24.87762741146 2.11042
Vanguard ESG U.S. Stock ETF 0 32.395678092399 1.26927
SPDR S&P SmallCap 600 ESG ETF 0.10491 18.952570684239 1.85316
iShares ESG Aware MSCI USA Small-Cap ETF 0.045 33.616398243045 1.49366
Fidelity MSCI Health Care Index ETF 0.01307 13.390080209527 1.46057
ProShares Hedge Replication ETF 0.00548 5.9237999659878 1.47892
Humankind US Stock ETF 0.00495 18.809430395549 1.99919
First Trust Innovation Leaders ETF 0.50718 45.144023838428 0.51521
iShares Morningstar Small-Cap ETF 0.01843 30.095066471445 1.60498
iShares Morningstar Small-Cap Growth ETF 0.02041 33.628071953382 0.72598
iShares Morningstar Small Cap Value ETF 0.01642 26.701717953559 2.50476
iShares Russell 2000 Growth ETF 0.06617 38.042556988 0.6026
iShares Russell 3000 ETF 0.00135 32.57283798366 1.43482
iShares Morningstar Small-Cap ETF 0.01843 391.25300933451 1.60498
iShares Morningstar Small-Cap Growth ETF 0.02041 680.05582339508 0.72598
iShares Morningstar Small-Cap Value ETF 0.01642 227.12514109528 2.50476
Direxion Daily S&P Biotech Bull 3x Shares 0.13311 4067.9190751445 0.25924
SPDR S&P 1500 Momentum Tilt ETF 0.00007 38.251249368151 1.12176
Nuveen ESG Small-Cap ETF 0.0523 29.971671388102 1.41019
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02267 35.452103849597 1.75869
Invesco S&P SmallCap Health Care ETF 0.64942 27.32109603618 0.41696
Invesco S&P SmallCap 600 Revenue ETF 0.01521 30.924461412599 1.94562
ProShares Ultra SmallCap600 0.04886 49.800399201597 1.83727
Schwab U.S. Small-Cap ETF 0.02468 34.281650071124 1.51433
Schwab U.S. Broad Market ETF 0.00159 32.5 1.43354
SPDR S&P 600 Small Cap Growth ETF 0.05894 34.267040149393 1.33495
SPDR S&P 600 Small Cap Value ETF 0.08162 29.161010046158 2.34209
SPDR Portfolio MSCI Global Stock Market ETF 0.00775 23.600605143722 2.19607
SPDR Portfolio S&P 600 Small Cap ETF 0.06937 31.781914893617 1.84119
SPDR Portfolio S&P 1500 Composite Stock Market ETF 0.00152 31.619629696207 1.46083
Syntax Stratified SmallCap ETF 0.14556 13.508906292462 1.639
iShares U.S. Tech Breakthrough Multisector ETF 0.01435 37.5 0.73986
FlexShares Morningstar US Market Factor Tilt Index Fund 0.00601 32.205226109465 1.69572
ProShares UltraPro Russell2000 0.01937 89.821266282945 1.47873
Vanguard S&P Small-Cap 600 Growth ETF 0.06 30.308661092185 1.37064
Vanguard S&P Small-Cap 600 ETF 0.07 32.617736315612 1.89226
Vanguard S&P Small-Cap 600 Value ETF 0.08 29.525999744474 2.40883
SPDR S&P 1500 Value Tilt ETF 0.00374 27.14840508514 2.3833
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.07 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0.03 35.648084105685 1.48801



Supervisor Cargo Pagamento Ano de nascimento
Dr. Terry J. Rosen Ph.D. Co-Founder, Chairman & CEO 756.11k 1960 (64 ano)
Mr. Robert C. Goeltz II Principal Financial Officer & CFO 745.29k 1973 (51 ano)
Dr. Juan Carlos Jaen Ph.D. Co- Founder & President 931.14k 1958 (66 anos)
Dr. Jonathan Yingling Ph.D. Chief Scientific Officer N/A 1969 (55 anos)
Ms. Jennifer A. Jarrett M.B.A. Chief Operating Officer 925.29k 1971 (53 ano)
Mr. Alexander Azoy VP of Finance & Principal Accounting Officer N/A 1976 (48 anos)
Dr. Dimitry S.A. Nuyten M.D., Ph.D. Chief Medical Officer 700.34k 1976 (48 anos)
Dr. K. Christopher Garcia Ph.D. Co-Founder & Member of Scientific Advisory Board N/A
Ms. Carolyn C. Tang J.D. General Counsel & Corporate Secretary 1979 (45 anos)
Holli Kolkey Vice President of Corporate Communications

Endereço: United States, Hayward, CA , 3928 Point Eden Way - abrir no Google Maps, abrir mapas Yandex
Site: http://www.arcusbio.com